Hemispherx Biopharma and USAMRIID to Present New Discoveries Concerning the Efficacy of Ampligen(R) Against the Ebola Virus at Upcoming International Symposium on Filoviruses
12 févr. 2015 08h30 HE
|
AIM ImmunoTech Inc.
Ampligen® May Be an Important Candidate for EBOV Testing in West Africa
PHILADELPHIA, Feb. 12, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or...
Hemispherx: U.S. Army Scientists (USAMRIID) Find Ampligen(R) Produces 100% Survival Rate in Ebola Virus Rodent Study
02 févr. 2015 08h30 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, Feb. 2, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today the results of a new efficacy study of Ampligen® in a...
USAMRIID Reports Genetic Changes in Ebola Virus May Impede Potential Treatments
26 janv. 2015 08h30 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, Jan. 26, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today that in a new publication in the journal mBio, scientists at...
U.S. Unprepared for Ebola, According to Journal of American Physicians and Surgeons
15 déc. 2014 10h20 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Dec. 15, 2014 (GLOBE NEWSWIRE) -- Despite spending billions on biological defense and pandemic preparedness, the U.S. is woefully unprepared, as recent experience with Ebola...
Hemispherx Announces Data Showing Inhibition of Ebola by Ampligen(R) Enlarged by Howard University Research
09 déc. 2014 09h51 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Dec. 9, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today that it has received a new research report (dated December 5,...
Helmsley Charitable Trust Announces $2.2 Million in Emergency Funding for Ebola Response Efforts
18 nov. 2014 09h33 HE
|
The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, Nov. 18, 2014 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust today announced a $2.2 million grant to GlobalGiving to support both local and international...
Plandai Biotechnology Could Offer Potential Anti-Viral Protection With Phytofare(TM) Catechin Complex Entrapped in Pheroid(R)
18 nov. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - November 18, 2014) - Plandaí Biotechnology (OTCQB: PLPL) entered into an agreement late last year with North West University in South Africa, that will allow it to use the...
CONNECTICUT CHILDREN'S TO HOST EBOLA WEBINAR NOVEMBER 19
17 nov. 2014 16h58 HE
|
Connecticut Childrens Medical Center
HARTFORD, Conn., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Ebola seems to be all anyone is talking about these days and with the most recent case now confirmed in New York City, many are scrambling with...
Ampligen(R) Blocks Critical Ebola Viral Disease (EVD) Protein Which is Linked to High Mortality in Man
17 nov. 2014 09h08 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 17, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today that it had received a new research report from Professor...
UBA Commits $1million to the Ebola Fight
13 nov. 2014 07h30 HE
|
The Tony Elumelu Foundation
Lagos, Nigeria, Nov. 13, 2014 (GLOBE NEWSWIRE) -- The United Bank for Africa (UBA) Board Chairman, Tony O Elumelu,
has announced the donation of $1million, to assist the fight
against Ebola, currently...